Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.29
-0.04 (-0.39%)
Mar 6, 2026, 9:57 AM EST - Market open
Ocular Therapeutix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 51.95 | 63.72 | 58.44 | 51.49 | 43.52 | Upgrade
|
| Revenue Growth (YoY) | -18.47% | 9.03% | 13.49% | 18.32% | 150.08% | Upgrade
|
| Cost of Revenue | 203.67 | 133.26 | 66.34 | 58 | 54.49 | Upgrade
|
| Gross Profit | -151.72 | -69.54 | -7.89 | -6.51 | -10.97 | Upgrade
|
| Selling, General & Admin | 118.3 | 91.34 | 74.49 | 72.15 | 67.07 | Upgrade
|
| Operating Expenses | 118.3 | 91.34 | 74.49 | 72.15 | 67.07 | Upgrade
|
| Operating Income | -270.02 | -160.88 | -82.38 | -78.65 | -78.04 | Upgrade
|
| Interest Expense | -11.84 | -13.58 | -11.34 | -7.02 | -6.67 | Upgrade
|
| Interest & Investment Income | 18.36 | 20.28 | 3.98 | 0.8 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.44 | -0.48 | -5.19 | 13.84 | 78.12 | Upgrade
|
| EBT Excluding Unusual Items | -265.94 | -154.66 | -94.93 | -71.04 | -6.55 | Upgrade
|
| Merger & Restructuring Charges | - | -1.6 | - | - | - | Upgrade
|
| Other Unusual Items | - | -37.25 | 14.19 | - | - | Upgrade
|
| Pretax Income | -265.94 | -193.51 | -80.74 | -71.04 | -6.55 | Upgrade
|
| Net Income | -265.94 | -193.51 | -80.74 | -71.04 | -6.55 | Upgrade
|
| Net Income to Common | -265.94 | -193.51 | -80.74 | -71.04 | -6.55 | Upgrade
|
| Shares Outstanding (Basic) | 187 | 158 | 80 | 77 | 76 | Upgrade
|
| Shares Outstanding (Diluted) | 187 | 158 | 86 | 83 | 82 | Upgrade
|
| Shares Change (YoY) | 18.31% | 84.90% | 3.57% | 0.59% | 35.24% | Upgrade
|
| EPS (Basic) | -1.42 | -1.22 | -1.01 | -0.92 | -0.09 | Upgrade
|
| EPS (Diluted) | -1.42 | -1.22 | -1.02 | -0.97 | -0.98 | Upgrade
|
| Free Cash Flow | -216.89 | -135.97 | -76.32 | -63.32 | -66.74 | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -0.86 | -0.89 | -0.77 | -0.81 | Upgrade
|
| Gross Margin | -292.04% | -109.13% | -13.51% | -12.64% | -25.20% | Upgrade
|
| Operating Margin | -519.75% | -252.47% | -140.96% | -152.74% | -179.31% | Upgrade
|
| Profit Margin | -511.90% | -303.67% | -138.15% | -137.95% | -15.06% | Upgrade
|
| Free Cash Flow Margin | -417.50% | -213.37% | -130.59% | -122.96% | -153.36% | Upgrade
|
| EBITDA | -265.69 | -157.1 | -79.4 | -76.55 | -75.62 | Upgrade
|
| EBITDA Margin | - | -246.53% | -135.86% | -148.65% | -173.74% | Upgrade
|
| D&A For EBITDA | 4.32 | 3.79 | 2.98 | 2.11 | 2.42 | Upgrade
|
| EBIT | -270.02 | -160.88 | -82.38 | -78.65 | -78.04 | Upgrade
|
| EBIT Margin | - | -252.47% | -140.96% | -152.74% | -179.31% | Upgrade
|
| Revenue as Reported | 51.95 | 63.72 | 58.44 | 51.49 | 43.52 | Upgrade
|
| Advertising Expenses | 0.51 | 0.92 | 0.88 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.